ArticleCureus2025
Benchmarking Pre-National Action Plan Systemic Antimicrobial Consumption in Tanzania, 1998-2005: A Historical Longitudinal Defined Daily Dose Analysis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Geospatial analysis of regional variations in antibiotic consumption in Tanzania from 2020 to 2024 using the electronic logistics management information system.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background Antimicrobial consumption (AMC) data in Tanzania prior to the 2017 National Action Plan on Antimicrobial Resistance (NAP-AMR) are scarce, limiting our understanding of historical usage patterns. Objective To establish a national baseline of systemic AMC in Tanzania from 1998 to 2005 using the World Health Organization's Defined Daily Dose (DDD) methodology. Methods A retrospective longitudinal analysis of antimicrobial import records from the Tanzania Medicines and Medical Devices Authority was conducted, expressing consumption as DDD per 1,000 inhabitants per day (DID). Results Between 1998 and 2005, annual AMC ranged from 0.45 to 13.32 DID, predominantly antibacterials (82.6%), with cumulative consumption of 51.9 DID. Oral formulations and Access category antibiotics dominated usage. Conclusion These historical AMC estimates provide a valuable benchmark for contextualizing and informing future antimicrobial stewardship efforts in Tanzania.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.